Israel Englander Replimune Group, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,154,821 shares of REPL stock, worth $14.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,154,821

Previous 3,118,035 62.96%

Holding current value

$14.4 Million

Previous $28.1 Million 54.9%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $15.9 Million - $22 Million	-1,963,214 Reduced 62.96%	1,154,821 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $13.3 Million - $25.1 Million	2,656,173 Added 575.1%	3,118,035 $28.1 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $3.07 Million - $4.16 Million	446,836 Added 2973.75%	461,862 $3.77 Million
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $2.62 Million - $6.29 Million	-388,847 Reduced 96.28%	15,026 $126,000
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $2.88 Million - $4.44 Million	-184,088 Reduced 31.31%	403,873 $9.38 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $5.46 Million - $9.09 Million	312,465 Added 113.42%	587,961 $10.4 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $2.35 Million - $3.83 Million	137,383 Added 99.47%	275,496 $7.49 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $563,893 - $764,509	36,147 Added 35.45%	138,113 $2.39 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $1.18 Million - $1.77 Million	88,703 Added 668.8%	101,966 $1.78 Million
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $1.38 Million - $2.69 Million	-90,563 Reduced 87.23%	13,263 $225,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $391,469 - $527,244	15,394 Added 17.41%	103,826 $2.81 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $902,784 - $1.23 Million	-31,152 Reduced 26.05%	88,432 $2.62 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $677,217 - $935,509	23,762 Added 24.8%	119,584 $4.59 Million
Q1 2021 May 17, 2021	SELL	$30.22 - $45.57 $3.59 Million - $5.42 Million	-118,842 Reduced 55.36%	95,822 $2.92 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $4.79 Million - $10.7 Million	203,618 Added 1843.36%	214,664 $8.19 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $208,217 - $298,242	11,046 New	11,046 $254,000
Q2 2020 Aug 14, 2020	SELL	$9.76 - $25.95 $581,715 - $1.55 Million	-59,602 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.9 - $19.08 $309,648 - $663,831	-34,792 Reduced 36.86%	59,602 $594,000
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $1.1 Million - $1.62 Million	94,394 New	94,394 $1.36 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $616M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account